|
1
|
Baramova EN, Bajou K, Remacie A, L’Hoir C,
Krell HW, Weidle UH and Foidart JM: Involvement of PA/plasmin
system in the processing of pro-MMP-9 and in the second step of
pro-MMP-2 activation. FEBS Lett. 405:157–162. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Monea S, Lehit K, Keski-Oja and Mignatii
P: Plasmin activates pro-matrix metalloproteinases-2 with a
membrane-type 1 matrix metalloproteinase-dependent mechanism. J
Cell Physiol. 192:160–170. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arbeláez LF, Bergmann U, Tuuttila A,
Shanbhag VP and Stigbrand T: Interaction of matrix
metalloproteinases-2 and -9 with pregnancy zone protein and
α2-macroglobulin. Arch Biochem Biophys. 347:62–68. 1997.PubMed/NCBI
|
|
4
|
Beekman B, Drijfhout JW, Ronday HK and
Tekoppele JM: Fluorogenic MMP activity assay for plasma including
MMPs complexed to α2-macroglobulin. Ann NY Acad Sci. 878:150–156.
1999.PubMed/NCBI
|
|
5
|
Chen WT and Wang JY: Specialized surface
protrusions of invasive cells, invadopodia and lamellipodia, have
differential MT1-MMP, MMP-2 and TIMP-2 localization. Ann NY Acad
Sci. 878:361–370. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ding S, Zhang M, Zhao Y, Chen W, Yao G,
Zhang C, Zhang P and Zhang Y: The role of carotid plaque
vulnerability and inflammation in the pathogenesis of acute
ischemic stroke. Am J Med Sci. 336:27–31. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alvarez B, Ruiz C, Chacon P, Alvarez-Sabin
J and Matas M: Serum values of metalloproteinase-2 and
metalloproteinase-9 as related to unstable plaque and inflammatory
cells in patients with greater than 70% carotid artery stenosis. J
Vasc Surg. 40:469–475. 2004.PubMed/NCBI
|
|
8
|
Kanoh Y, Akahoshi T, Ohara T, Ohtani N,
Mashiko T, Ohtani S, Egawa S and Baba S: Expression of matrix
metalloproteinase-2 and prostate-specific antigen in localized and
metastatic prostate cancer. Anticancer Res. 22:1813–1818.
2002.PubMed/NCBI
|
|
9
|
Kanoh Y, Ohtani H, Egawa S, Baba S and
Akahoshi T: Changes of proteases and proteinase inhibitors in
androgen-dependent advanced prostate cancer patients with
α2-macroglobulin deficiency. Clin Lab. 58:217–225. 2012.PubMed/NCBI
|
|
10
|
Kanoh Y and Ohtani H: Levels of
interleukin-6, CRP and α2-macrogloburin in cerebrospinal fluid
(CSF) and serum as indicator of blood-CSF barrier damage. Biochem
Mol Biol Int. 43:269–278. 1997.
|
|
11
|
dos Anjos BL and Grotto HZ: Evaluation of
C-reactive protein and serum amyloid A in the detection of
inflammatory and infectious disease in children. Clin Chem Lab Med.
48:493–499. 2010.PubMed/NCBI
|
|
12
|
Fujiwara H, Suchi K, Okamura H, Umehara S,
Toda M, Shiozaki A, Kubota T, Ichikawa D, Okamoto K, Ochiai T,
Kokuba Y, Sonoyama T and Otsuji E: Elevated serum CRP levels after
induction chemoradiotherapy reflect poor treatment response in
association with IL-6 in serum and local tumor site in patients
with advanced esophageal cancer. J Surg Oncol. 103:62–68. 2011.
View Article : Google Scholar
|
|
13
|
Imazio M, Brucato A, Maestroni S, Cumetti
D, Dominelli A, Natale G and Trinchero R: Prevalence of C-reactive
protein elevation and time course of normalization in acute
pericarditis: implication for the diagnosis, therapy, and prognosis
of pericarditis. Circulation. 213:1092–1097. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kablak-Ziembicka A, Przewlocki T,
Sokolowski A, Tracz W and Podolec P: Carotid intima-media
thickness, hs-CRP and TNF-α are independently associated with
cardiovascular event risk in patients with atherosclerotic
occlusive disease. Atherosclerosis. 214:185–190. 2011.
|
|
15
|
Kanoh Y, Ohara T and Akahoshi T: Acute
inflammatory biomarkers in cerebrospinal fluid as indicators of
blood cerebrospinal fluid barrier damage in Japanese subjects with
infectious meningitis. Clin Lab. 57:37–46. 2011.
|
|
16
|
Smith JW, Colombo JL and McDonald TL:
Comparison of serum amyloid A and C-reactive protein as indicators
of lung inflammation in corticosteroid treated and
non-corticosteroid cystic fibrosis patients. J Clin Lab Anal.
6:219–224. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yap SH, Moshage HJ, Hazenberg BP, Roelofs
MH, Bijizet J, Limburg PC, Aarden LA and van Rijiswijk MH: Tumor
necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6
stimulated synthesis of C-reactive protein (CRP) and serum amyloid
A (SAA) in primary cultures of human hepatocytes. Biochim Biophys
Acta. 1091:405–408. 1991. View Article : Google Scholar
|
|
18
|
Smith JW and McDonald TL: Production of
serum amyloid A and C-reactive protein by HepG2 cells stimulated
with combinations of cytokines or monocyte conditioned media: the
effects of prednisolone. Clin Exp Immunol. 90:293–299. 1992.
View Article : Google Scholar
|
|
19
|
Matsuda T, Hirano T, Nagasawa S and
Kishimoto T: Identification of α2 macroglobulin as a carrier
protein for IL-6. J Immunol. 142:148–152. 1989.
|
|
20
|
Kanoh Y, Ohtani H, Egawa S, Baba S and
Akahoshi T: Levels of acute inflammatory biomarkers in advanced
prostate cancer patients with α2-macroglobulin deficiency. Int J
Oncol. 39:1553–1558. 2011.
|
|
21
|
Kanoh Y, Ohtani H, Egawa S, Baba S and
Akahoshi T: Clinicopathological characteristic of
androgen-dependent advanced prostate cancer patients with
α2-macroglobulin deficiency. Int J Oncol. 41:39–45. 2012.PubMed/NCBI
|
|
22
|
Mountain C: A new international staging
system for lung cancer. Chest. 89:S225–S233. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fujimoto N, Mouri N, Iwata K, Ohuchi E,
Okada Y and Hayakawa T: A one-step sandwich enzyme immunoassay for
human matrix metalloproteinase 2 (72-kDa gelatinase/type IV
collagenase) using monoclonal antibodies. Clin Chim Acta.
221:91–103. 1993. View Article : Google Scholar
|
|
24
|
Noh S, Jung JJ, Jung M, Kim TS, Park CH,
Lim SJ, Jeung HC, Cheol H, Chung HC and Rha SY: MMP-2 as a putative
biomarker for carcinomatosis in gastric cancer.
Hepatogastroenterology. 58:2015–2019. 2011.PubMed/NCBI
|
|
25
|
Noh S, Jung JJ, Jung M, Kim TS, Park CH,
Lim SJ, Jeung HC, Cheol H, Chung HC and Rha SY: Body fluid MMP-2 as
a putative biomarker in metastatic breast cancer. Oncol Lett.
3:699–703. 2012.PubMed/NCBI
|
|
26
|
Safranek J, Pesta M, Holubec L, Kulda V,
Dreslerova J, Vrzalova J, Topolcan O, Pesek M, Finek J and Treska
V: Expression of MMP-7, MMP-9 TIMP-1 and TIMP-2 mRNA in lung tissue
of patients with non-small cell lung cancer (NSCLC) and benign
pulmonary disease. Anticancer Res. 29:2513–2517. 2009.PubMed/NCBI
|
|
27
|
Peng WJ, Zhang JQ, Wang BX, Pan HE, Lu MM
and Wang J: Prognostic value of matrix metalloproteinase 9
expression in patients with non-small cell lung cancer. Clin Chim
Acta. 413:1121–1126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bataille R, Boccadoro M, Klein B, Durie
and Pileri A: C-reactive protein and beta-2 microglobulin produce a
simple and powerful myeloma staging system. Blood. 80:733–737.
1992.PubMed/NCBI
|
|
29
|
Firooz N, Albert D, Wallace D, Ishimori M,
Berel D and Weisman M: High-sensitivity C-reactive protein and
erythrocyte sedimentation rate in systemic lupus erythematosus.
Lupus. 20:588–597. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chua TC, Chong CH, Liauw W, Zhao J and
Morris DL: Inflammation markers in blood and serum tumor markers
predict survival in patients with epithelial appendiceal neoplasms
undergoing surgical cytoreduction and intraperitoneal chemotherapy.
Ann Surg. 256:342–349. 2012. View Article : Google Scholar
|
|
31
|
O’Dowd C, McRae LA, McMillian DC, Kirk A
and Milroy R: Elevated preoperative C-reactive protein predicts
poor cancer specific survival in patients undergoing resection for
non-small cell lung cancer. J Thorac Oncol. 5:988–992.
2010.PubMed/NCBI
|
|
32
|
Chan DC, Chen CJ, Chu HC, Chang WK, Yu JC,
Chen YJ, Wen LL, Huang SC, Ku CH, Liu YC and Chen JH: Evaluation of
serum amyloid A as a biomarker for gastric cancer. Ann Surg Oncol.
14:84–93. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cocco E, Bellone S, El-Sahwi K,
Cargnelutti M, Casagrande F, Buza N, Tavassoli FA, Siegel ER,
Visintin I, Ratanr E, Silasi DA, Azodi M, Schwartz PE, Rutherford
TJ, Pecorelli S and Santin AD: Serum amyloid A (SAA): a novel
biomarker for uterine serous papillary cancer. Br J Cancer.
101:335–341. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu C, Pan C, Shen J, Wang H and Yong L:
Identification of serum amyloid A in the serum of gastric cancer
patients by protein expression profiling. Oncol Lett. 3:1259–1262.
2012.PubMed/NCBI
|
